ACLA’s 2024 Advocacy Agenda

ACLA’s 2024 advocacy agenda promotes policy priorities in the areas of reimbursement, regulation, and preparedness & infrastructure, including laboratory workforce. As a whole, the advocacy agenda strives to promote policies that reflect the value of clinical laboratories, support innovation, and expand access to testing services that improve and save lives.

Learn More

ACLA Urges FDA to Withdraw Proposed Rule to Regulate Laboratory Developed Tests

In December 2023, ACLA submitted comments urging the FDA to withdraw its proposed rule to regulate laboratory developed tests (LDTs) as medical devices. FDA’s proposed rule, if finalized, would jeopardize the ongoing ability of laboratories to develop and offer innovative LDTs essential to delivering the latest scientific advances in diagnostics to patient care.

Learn More

Saving Access to Laboratory Services Act

In November 2023, Congress passed a short-term spending package that includes a one-year delay of implementation of Medicare payment cuts to clinical laboratory services. ACLA remains focused on securing a permanent solution to this problem through enactment of the bipartisan Saving Access to Laboratory Services Act (SALSA) in 2024.

Learn More

Supporting Patient Health:

Value of Laboratory Tests and Diagnostics

Accurate, reliable test results help provide a complete picture of health and align all players in the health system towards patient-centered care.

Learn More

Recent News & Updates

Policy Issues

Recent tweets